EUVIMEDEUVIMED entdecken
Crossref

Glut-1 exerts anti-tumor activity in glioma by regulating AKT / mTOR signaling pathway

Zhimei Li, Guofeng Zhang

Technology and Health Care · 2025

DOI: 10.1177/09287329241304910 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology and Health Care, 2025. Verfasst von Zhimei Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Glucose Transporter Type 1, Glioma, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Glioma is a common tumor in neurosurgery. Glut-1 is the main carrier of glucose uptake by cells and can provide energy through the glycolytic pathway. However, the role and related mechanisms of Glut-1 in glioma have not yet been elucidated.

Methods

Real time PCR and Western blot were done to assess Glut-1 level in glioma tumor tissues and adjacent tissues. Glioma U87 cells were separated into control group; Glut-1 negative control (NC group); and Glut-1 siRNA group followed by analysis of Glut-1 expression, cell proliferation by MTT assay, cell invasion, cell apoptosis and cycle by flow cytometry and AKT / mTOR signaling proteins level by Western blot.

Results

Glut-1 expression was significantly increased in the tissues of glioma patients (P < 0.05) compared to adjacent tissues and its level was related to tumor size, pathological grade and survival. Down-regulating the expression of Glut-1 can significantly inhibit tumor cell proliferation and invasion, increase apoptosis and induce G0 phase of cell cycle arrest, and inhibit the expression of AKT / mTOR signaling proteins phosphorylation (P < 0.05).

Conclusions

Glut-1 level in glioma tissues is significantly increased, which is related to the pathological features. Down-regulating Glut-1 can inhibit glioma by regulating the AKT / mTOR signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesGlucose Transporter Type 1GliomaProto-Oncogene Proteins c-aktBrain NeoplasmsHumansSignal TransductionCell ProliferationApoptosisCell Line, TumorMaleFemaleMiddle AgedAdult

Stichwörter der Autor:innen

AKT / mTOR signaling pathwayapoptosisgliomaglut-1proliferation

Substanzen

TOR Serine-Threonine KinasesGlucose Transporter Type 1Proto-Oncogene Proteins c-aktMTOR protein, humanSLC2A1 protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

Zitieren

APA

Li, Z., & Zhang, G. (2025). Glut-1 exerts anti-tumor activity in glioma by regulating AKT / mTOR signaling pathway. Technology and Health Care. https://doi.org/10.1177/09287329241304910

Vancouver

Li Z, Zhang G. Glut-1 exerts anti-tumor activity in glioma by regulating AKT / mTOR signaling pathway. Technology and Health Care. 2025. doi:10.1177/09287329241304910

BibTeX
@article{Li2025,
  author = {Li, Zhimei and Zhang, Guofeng},
  title = {Glut-1 exerts anti-tumor activity in glioma by regulating AKT / mTOR signaling pathway},
  journal = {Technology and Health Care},
  year = {2025},
  doi = {10.1177/09287329241304910}
}
Kostenlos starten →